-Yasuhiko Tomino Researcher Activity Profile

Research Author Detailed Information 

Yasuhiko Tomino Publication Rate By Year

Yasuhiko Tomino has published 1 paper(s) in 1997, 1 paper(s) in 2004, 1 paper(s) in 2005, 20 paper(s) in 2007, 18 paper(s) in 2008, for a total of 41 research publications in total.

Yasuhiko Y Tomino Author Information

LAST NAME: tomino

FIRST NAME: Yasuhiko

INITIALS: y

AFFILIATION:

Papers

Yasuhiko Tomino's Publication Record

1. Analysis of IgA nephropathy by serial renal biopsies in the ddY mouse: heterogeneous progression of glomerulonephritis. Year Published: 2005
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
2. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. Year Published: 2007
University of Alabama at Birmingham, Department of Microbiology, Birmingham, AL 35294-2170, USA. shitoshi@uab.edu
3. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure. Year Published: 2007
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd, Hyogo, Japan.
4. Peritoneal fibrosis intervention. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
5. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Year Published: 2007
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.
6. Leukocytapheresis (LCAP) for the treatment of rheumatoid arthritis on a maintenance hemodialysis patient. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
7. [Chronic glomerulonephritis] Year Published: 2007
8. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. yasu@med.juntendo.ac.jp
9. The role of podocytes in proteinuria. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
10. Quantitative evaluation of time-resolved fluorescence microscopy using a new europium label: Application to immunofluorescence imaging of nitrotyrosine in kidneys. Year Published: 2007
Department of Forensic Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan.
11. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan, yasu@med.juntendo.ac.jp.
12. The role of podocytes in proteinuria. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
13. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
14. Quantitative evaluation of time-resolved fluorescence microscopy using a new europium label: application to immunofluorescence imaging of nitrotyrosine in kidneys. Year Published: 2007
Department of Forensic Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.
15. The role of podocytes in proteinuria. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
16. Year Published: 2008
1Department of Internal Medicine, Division of Nephrology, Juntendo University School of Medicine, 2Division of Nephrology, Juntendo Nerima Hospital, Tokyo, 3Division of Nephrology, Juntendo Shizuoka Hospital, Nagaoka, Izunokuni City, Shizuoka, Japan.
17. Effect of educational hospitalization on chronic kidney disease (CKD) patients. Year Published: 2008
Department of Internal Medicine, Division of Nephrology, Juntendo University School of Medicine, Tokyo, Japan.
18. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. yasu@med.juntendo.ac.jp
19. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
20. Peritoneal fibrosis intervention. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
21. Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
22. Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. yasu@med.juntendo.ac.jp.
23. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
24. Leukocytapheresis (LCAP) for the treatment of rheumatoid arthritis on a maintenance hemodialysis patient. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
25. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Year Published: 2007
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
26. Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. Year Published: 2008
1Division of Nephrology-Hypertension, Department of Internal Medicine, Airlangga University School of Medicine, Surabaya, Indonesia and 2Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
27. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. Year Published: 2008
University of Alabama at Birmingham, Birmingham, Alabama, USA. Juntendo University School of Medicine, Tokyo, Japan. University of Tennessee Health Science Center, Memphis, Tennessee, USA. Charles University, School of Medicine, Prague, Czech Republic.
28. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 1138421, Japan.
29. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 1138421, Japan.
30. Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
31. Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. Year Published: 2008
Division of Nephrology-Hypertension, Department of Internal Medicine, Airlangga University School of Medicine, Surabaya, Indonesia.
32. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
33. The role of the left somatosensory cortex in human hand movement. Year Published: 1997
Fifth Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
34. Relationship between Abdominal Fat Accumulation and Insulin Resistance in Hemodialysis Patients. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine.
35. Prediction of diagnosis of immunoglobulin a nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
36. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Year Published: 2008
Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
37. Osteodystrophy in Indonesian haemodialysis patients. Year Published: 2004
Division of Nephrology and Hypertension, Dr Soetomo Hospital, Faculty of Medicine, Airlangga University, Surabaya, Indonesia. drdjokosantoso@yahoo.com
38. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. Year Published: 2008
University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
39. Suppressive activity of pemirolast potassium, an antiallergic drug, on glomerulonephritis. Studies in glomerulonephritis model rats and in patients with chronic glomerulonephritis concurrently affected by allergic rhinitis. Year Published: 2008
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
40. Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration. Year Published: 2008
Department of Internal Medicine, Division of Nephrology, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
41. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure. Year Published: 2007
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd, Hyogo, Japan.